Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-25

FDA Approved: PALONOSETRON HYDROCHLORIDE — Supplemental Application (Eugia US LLC)

View source ↗

Summary

The FDA approved a supplemental application for palonosetron hydrochloride (generic) submitted by Eugia US LLC under ANDA204702, adding to the approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palonosetron hydrochloride (Palonosetron hydrochloride)

Snippet

SUPPL AP for PALONOSETRON HYDROCHLORIDE (PALONOSETRON HYDROCHLORIDE)